Skip to main content
. Author manuscript; available in PMC: 2025 Aug 25.
Published in final edited form as: BioDrugs. 2021 Aug 24;35(5):529–545. doi: 10.1007/s40259-021-00494-7

Table 2.

Examples of DMSO-free cryopreservation of NK and T cells.

Cell type CPA Post-thaw function
NK-92 Trehalose encapsulated in chitosan-TPP nanoparticles Viability comparable to DMSO CPA; higher cytotoxicity compared to DMSO CPA[141]
NK-92 7.5% COOH-PLL + 5% dextran-40 + ectoine Viability comparable to DMSO CPA[169]
NK-92 5% Dextran-40 + 7.5% COOH-PLL Viability and cytotoxicity comparable to DMSO-based CPA[205]
Jurkat T cells 300 mM trehalose, 10% glycerol and 0.01% ectoine Higher viability compared to DMSO CPA[202]
Jurkat T cells Sucrose + glycerol + isoleucine CPA optimization study; no direct comparison to DMSO CPA[203]
Jurkat T cells Sucrose + glycerol; Trehalose + glycerol Improved post-thaw function compared to DMSO[204]
PBMC-derived helper T cells; cytotoxic T cells; NKT cells Sucrose + glycerol + isoleucine (SGI); Trehalose + glycerol + isoleucine (TGI); Maltose + glycerol + isoleucine (MGI) Comparable recovery for helper and cytotoxic T cells to DMSO CPA; highest recovery with helper T cells in TGI; poor recovery for NKT cells[111]

COOH: carboxylated poly-L-lysine; CPA: cryoprotective agent; DMSO: dimethylsulfoxide; NK: natural killer